22 May 2025
Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer
Sponsored by Shockwave Medical
Anchorperson:
J. Spratt
Spokesperson:
F. Woitek
Summary
Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic option for refractory angina. The session covers its mechanism of action, step-by-step implantation procedure, and guidance on post-procedure patient follow-up.
Learning Objectives
- To understand the true impact and occurrence of refractory angina
- To learn about the mechanism of action and implanting procedure of the Shockwave Reducer
- To learn about both the clinical data and real-life examples supporting the efficacy of the Shockwave Reducer